The paper test measures the level of neutralizing antibodies in a blood sample and could help people decide what protections they should take against infection.

The technology could be developed as a rapid diagnostic for Covid-19 or other emerging pathogens.

The tabletop diagnostic yields results in an hour and can be programmed to detect variants of the SARS-CoV-2 virus.

Biological sensors developed by MIT spinout Glympse Bio could help clinicians make decisions for individual patients.

Specialized nanoparticles create a “breath signal” that could be used to diagnose pneumonia and other infectious or genetic diseases.

Company working with Sikes Lab to test feasibility of low-cost diagnostic that could be manufactured by the millions each day.

Hadley Sikes designs simple-to-use diagnostic devices that could benefit patients around the world.

Study shows that a simple urine test can reveal the presence of lung cancer in mice.

Noninvasive device could benefit patients with kidney disease, congestive heart failure, or dehydration.